Figure 1. Random-Effects Linear Longitudinal Analysis of the Effect of Sulindac on the Number (Panel A) and Size (Panel B) of Polyps, According to the Intention to Treat and to the Treatment Actually Received.
All subjects were included in the intention-to-treat analysis, and all subjects who completed the study (16 in the sulindac group and 14 in the placebo group) were included in the analysis according to the treatment received. There were no significant differences between groups in the number or size of polyps in either analysis.